Property | Value |
?:abstract
|
-
Several months after the sudden emergence of SARS-CoV-2 and COVID-19, the understanding of the appropriate host immune response to a virus totally unknown of human immune surveillance is still of major importance. By international definition, COVID-19 falls in the scope of septic syndromes (organ dysfunction due to dysregulated host response to an infection) in which immunosuppression is a significant driver of mortality. Sepsis-induced immunosuppression is mostly defined and monitored by the measurement of decreased expression of HLA-DR molecules on circulating monocytes (mHLA-DR). In this interim review, we summarise the first mHLA-DR results in COVID-19 patients. In critically ill patients, results homogenously indicate a decreased mHLA-DR expression, which, along with profound lymphopenia and other functional alterations, is indicative of a status of immunosuppression.
|
is
?:annotates
of
|
|
?:creator
|
|
?:doi
|
|
?:doi
|
|
?:journal
|
-
Cytometry._Part_A_:_the_journal_of_the_International_Society_for_Analytical_Cytology
|
?:license
|
|
?:pmid
|
|
?:pmid
|
|
?:publication_isRelatedTo_Disease
|
|
is
?:relation_isRelatedTo_publication
of
|
|
?:source
|
|
?:title
|
-
Monocyte HLA-DR measurement by flow cytometry in COVID-19 patients: an interim review.
|
?:type
|
|
?:year
|
|